Venetoclax for Multiple Myeloma: The Phase 3 BELLINI Trial

Video

Sponsored in Part by AbbVie/Content Independently Developed by Targeted Oncology. Dr. Shaji Kumar reviews data from his BELLINI clinical trial studying venetoclax paired with bortezomib and dexamethasone for multiple myeloma treatment.

Related Videos
Related Content